¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"arginine vasopressin"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® vasopressin ÇÑ±Û ¹Ù¼ÒÇÁ·¹½Å
¼³¸í   
  ½Ã»óÇϺΠ½Å°æÇÙÀÇ ½Å°æ¼¼Æ÷¿¡¼­ ¸¸µé¾îÁö¸ç, ³úÇϼöü ÈÄ¿±¿¡ ÀúÀåµÇ´Â 2Á¾ÀǠȣ¸£¸ó ÁßÀÇ Çϳª. Ç×ÀÌ´¢È£¸£¸ó(antidiuretic hormone, ADH)À̶ó°íµµ ÇÑ´Ù. ´Ù¸¥ 1Á¾Àº ¿Á½ÃÅä½ÅÀÌ´Ù. ¸ð¼¼Ç÷°ü°ú ¼¼µ¿¸ÆÀ» ±¸¼ºÇϴ ÆòȰ±Ù Á¶Á÷ÀÇ ¼öÃàÀ» ÀÚ±ØÇÏ¿© Ç÷¾ÐÀ» »ó½Â½Ã۴ ÀÛ¿ëÀÌ ÀÖ´Ù. Ã¢ÀÚ±ÙÀ°ÀÇ ¼öÃàÀ» ÀÚ±ØÇϰí, ²ÞƲ¿îµ¿À» Áõ°­½Ã۸ç, Àڱÿ¡µµ ¿µÇâÀ» ÁØ´Ù. ¶ÇÇÑ ¿ä¼¼°ü ¿øÀ§ºÎÀÇ »óÇǼ¼Æ÷¿¡ Æ¯¼öÇÑ ÀÛ¿ëÀ» ÀÏÀ¸ÄÑ, °íÇü¹°ÀÇ Èí¼ö¿Í´Â °ü°è¾øÀÌ ¼öºÐÀÇ ÀçÈí¼ö¸¦ Ç×Áø½ÃÄÑ ¿ÀÁÜÀ» ³óÃà½ÃŲ´Ù. ¹Ù¼ÒÇÁ·¹½ÅÀº ÇÕ¼º¿¡ ÀÇÇØ¼­µµ ¸¸µé¾îÁö°í, ¶ÇÇÑ °¡ÃàÀÇ Çϼöü ÈÄ¿±À¸·ÎºÎÅ͵µ ¾ò¾îÁö¸ç, Ç×ÀÌ´¢Á¦·Î¼­ ÁÖ»ç¾×À¸·Îµµ »ç¿ëµÈ´Ù. °í¸® ¸ð¾çÀ¸·Î Æú¸®ÆéƼµå°áÇÕÀ» ÀÌ·é´Ù. Æ÷À¯·ù¿¡¼­ ±¤¹üÀ§ÇϰԠº¼ ¼ö Àִ °ÍÀ¸·Î ÄáÆÏ¿¡¼­ ¼öºÐÀÇ ÀçÈí¼ö¸¦ ÃËÁøÇϴ ¹°Áú·Î ÀÛ¿ëÇÑ´Ù. ¸ð¼¼Ç÷°üÀ» ¼öÃà½ÃÄÑ Ç÷¾ÐÀ» ³ôÀ̴ ÀÛ¿ëÀÌ ÀÖÀ¸¹Ç·Î ÀúÇ÷¾Ð Ä¡·á¿¡ ÀÌ¿ëµÈ´Ù. 
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • arginine
    ¾Æ¸£Áö´Ñ
  • vasopressin
    ¹Ù¼ÒÇÁ·¹½Å
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • vasopressin
    ¹Ù¼ÒÇÁ·¹½Å
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • vasopressin
    ¹Ù¼ÒÇÁ·¹½Å
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • arginine vasopressin
    ¾Ë±â´Ñ ¹Ù¼ÒÇÁ·¹½Å, ¾ËÁö´Ñ ¹Ù¼ÒÇÁ·¹½Å
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Desamino-8-7-arginine vasopressin
    ÀÏ-µ¥½º¾Æ¹Ì³ë-ÆÈ-Ä¥-¾Æ¸£±â´Ñ¹Ù¼ÒÇÁ·¹½Å
  • arginine decarboxylase reagent
    ¾Æ¸£±â´ÑŻī¸£º¹½ÇÈ¿¼Ò<--µ¥Ä«¸£º¹½Ç¶óÁ¦
  • arginine-glycine-aspartic acid
    Arginine-glycine-aspartic acid
  • arginine-insulin test
    ¾Æ¸£±â´Ñ-Àν¶¸°½ÃÇè
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • arginine vasopressin
    ¾Ë±â´Ñ ¹Ù¼ÒÇÁ·¹½Å, ¾ËÁö´Ñ ¹Ù¼ÒÇÁ·¹½Å
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • arginine decarboxylase reagent
    ¾Æ¸£±â´ÑŻī¸£º¹½ÇÈ¿¼Ò<--µ¥Ä«¸£º¹½Ç¶óÁ¦
  • arginine-glycine-aspartic acid
    Arginine-glycine-aspartic acid
  • arginine-insulin test
    ¾Æ¸£±â´Ñ-Àν¶¸°½ÃÇè
  • vasopressin
    ¹Ù¼ÒÇÁ·¹½Å
  • vasopressin
    ¹Ù¼ÒÇÁ·¹½Å.
  • vasopressin deficiency
    ¹Ù¼ÒÇÁ·¹½Å°áÇÌÁõ(¡­ÌÀù¹ñø).
  • vasopressin deficiency
    ¹Ù¼ÒÇÁ·¹½Å°áÇÌÁõ(¡­ÌÀù¹ñø)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • arginine vasopressin
    ¾Æ¸£Áö´Ñ ¹Ù¼ÒÇÁ·¹½Å
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • lysine vasopressin
    ¶óÀ̽Š¹Ù¼ÒÇÁ·¹½Å
  • vasopressin
    ¹Ù¼ÒÇÁ·¹½Å
  • arginine cycle
    ¾Æ¸£Áö´Ñ ȸ·Î(üÞÖØ)
  • arginine dihydrolase pathway
    ¾Æ¸£Áö´ÑµðÈ÷µå·Ñ·¹À̽º °æ·Î(ÌèÖØ)
  • arginine vasotocin
    ¾Æ¸£Áö´Ñ ¹Ù¼ÒÅä½Å
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • vasopressin
    ¹Ù¼ÒÇÁ·¹½Å
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
AVP abnormal vasopressin; actinomycin-vincristine-Platinol; ambulatory venous pressure; antiviral protei...
DDAVP, dDAVP 1-deamino-8-D-arginine vasopressin; 1-deamino-8-N-arginine vasopressin
DDAVP 1-Desamino-8-D-Arginine Vasopressin
  = Desmopression
ARVP arginine-vasopressin
DAVP deamino-arginine vasopressin
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
DDAVP 1,desamino-8-D-arginine vasopressin
AVP 3)H]arginine vasopressin
3H-AVP 3H-arginine-vasopressin
AVP 8-Arginine vasopressin
DGAVP Desglycinamide-Arginine Vasopressin
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • arginine-insulin test
    ¾Æ¸£±â´Ñ-Àν¶¸° ½ÃÇè
  • vasopressin
    ¹Ù¼ÒÇÁ·¹½Å, ¹ÙÁ¶ÇÁ·¹½Å
    1. ½Ã»óÇϺΠ½Å°æÇÙÀÇ ½Å°æ ¼¼Æ÷¿¡¼­ ¸¸µé¾îÁö¸ç, ³úÇϼöü ÈÄ¿±¿¡ ÀúÀåµÇ´Â 2Á¾ÀÇ È£¸£¸ó ÁßÀÇ Çϳª. ´Ù¸¥ 1Á¾Àº ¿Á½ÃÅä½ÅÀÌ´Ù. ¸ð¼¼Ç÷°ü°ú ¼¼µ¿¸ÆÀ» ±¸¼ºÇÏ´Â ÆòȰ±Ù Á¶Á÷ÀÇ ¼öÃàÀ» ÀÚ±ØÇÏ¿© Ç÷¾ÐÀ» »ó½Â½ÃŰ´Â ÀÛ¿ëÀÌ ÀÖ´Ù. Àå°ü±ÙÀÇ ¼öÃàÀ» ÀÚ±ØÇϰí, ¿¬µ¿À» Áõ°­½Ã۸ç, Àڱÿ¡µµ ¿µÇâÀ» ÁØ´Ù. ¶ÇÇÑ ¼¼´¢°ü ¿øÀ§ºÎÀÇ »óÇǼ¼Æ÷¿¡ Ư¼öÇÑ ÀÛ¿ëÀ» ÀÏÀ¸ÄÑ, °íÇü¹°ÀÇ Èí¼ö¿Í´Â °ü°è¾øÀÌ ¼öºÐÀÇ ÀçÈí¼ö¸¦ Ç×Áø½ÃÄÑ ¿ä¸¦ ³óÃà½ÃŲ´Ù. ¹Ù¼ÒÇÁ·¹½ÅÀº ÇÕ¼º¿¡ ÀÇÇØ¼­µµ ¸¸µé¾îÁö¸ç, ¶ÇÇÑ °¡ÃàÀÇ Çϼöü ÈÄ¿±À¸·ÎºÎÅ͵µ ¾ò¾îÁö¸ç, Ç×ÀÌ´¢Á¦·Î¼­ ÁÖ»ç¾×À¸·Î »ç¿ëµÈ´Ù. 2. Ç÷°üÀÇ ÆòȰ±ÙÀ» ¼öÃà½ÃŰ¹Ç·Î ¸»ÃÊÀúÇ×ÀÌ Ä¿Á®¼­ Ç÷¾ÐÀÌ »ó½ÂµÈ´Ù. ¶ÇÇÑ ½ÅÀå¿¡¼­ ¿ÀÁÜÀ» ³óÃà½ÃÄÑ ¼öºÐÀÇ ¹è¼³À» ¾ïÁ¦½ÃŲ´Ù. 3. ³úÇϼöü ÈÄ¿±¿¡¼­ ºÐºñµÇ´Â È£¸£¸ó. Ç×ÀÌ´¢ È£¸£¸óÀ̶ó°íµµ ÇÑ´Ù. Ç×ÀÌ´¢ ÀÛ¿ë°ú Ç÷¾Ð »ó½ÂÀÛ¿ëÀÌ ÀÖ´Ù. Ç÷°ü
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
arginine vasopressin [8-arginine]vasopressin; [Arg8]vasopressin;vasopressin containing an arginyl residue in position 8 (as in chickens and most mammals, including man); porcine vasopressin has a lysyl residue at position 8. All are vasopressors.
Synonym: argipressin.
(05 Mar 2000)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
vasopressin <protein> A peptide hormone released from the posterior pituitary lobe but synthesised in the hypothalamus. There are 2 forms, differing only in the amino acid at position 8: arginine vasopressin is widespread, while lysine vasopressin is found in pigs. Has antidiuretic and vasopressor actions. Used in the treatment of diabetes insipidus.
(18 Nov 1997)
vasopressin-converting aminopeptidase <enzyme> Activity found in brain which converts vasopressin into centrally active metabolites
Registry number: EC 3.4.11.-
Synonym: vp-c aminopeptidase
(26 Jun 1999)
vasopressin level This test measures the amount of ADH in the serum. It is used to detect disorders that may affect the level of ADH in the serum. Normal values are: 0 to 4.7 pg/ml. Elevated ADH levels can indicate a CNS infection, fluid imbalance, CNS tumour, SIADH or acute porphyria. Low levels can indicate: diabetes insipidus or damage to the pituitary gland.
(27 Sep 1997)
vasopressin-resistant diabetes Diabetes insipidus due to inability of the kidney tubules to respond to antidiuretic hormone; X-linked inheritance, with full expression in males and partial defect in heterozygous females.
Synonym: vasopressin-resistant diabetes.
(05 Mar 2000)
receptors, vasopressin Specific molecular sites or structures on or in cells that vasopressins react or to which they bind in order to modify the function of the cells. Two types of vasopressin receptor exist, the v1 receptor and the v2 receptor. The v1 receptor can be subdivided into v1a and v1b (formerly v3) receptors.
(12 Dec 1998)
unit of vasopressin The pressor activity of 0.5 mg of the USP Posterior-pituitary Reference Standard; 1 mg of synthetic vasopressin corresponds to 600 IU.
(05 Mar 2000)
8-lysine vasopressin <chemical> 8-lysyl vasopressin. The porcine antidiuretic hormone most frequently used clinically. A cyclic nonapeptide with lysine in position 8 of the chain; it is used to treat diabetes insipidus and as haemostatic because of its vasoconstrictor action.
Pharmacological action: haemostatics, renal agents, vasoconstrictor agents.
Chemical name: Vasopressin, 8-L-lysine-
(12 Dec 1998)
arginine <amino acid> An essential amino acid, a major component of proteins and contains the guanido group that has a pKa of greater than 12, so that it carries a permanent positive charge at physiological pH. It becomes an essential amino acid when the body is under stress or is in an injured state.
Depressed growth results from lack of dietary arginine. Arginine deficiency syndrome is observed in human babies born with a phosphate synthetase deficiency. Normal growth and development in these infants are achieved by adding arginine to their diet. Arginine deficiency leads to carbamyl phosphate overproduction in the mitochondria due to inadequate ornithine supply. Arginine-deficient diets in males causes decreased sperm counts. Free and bound arginine are found in abundance in human male sperm and arginine has been found to stimulate sperm motility.
There are two sources of arginine, arginine in the food chain and free-form arginine from supplements. Food-source arginine is found in abundance in turkey, chicken and other meats. Nonfood-source arginine is called L-arginine and is created through a fermentation process which separates arginine from all other proteins. In the presence of food and other amino acids, L-arginine will act like food-source arginine but when L-arginine is separated from its nutrient boundaries by the removal of all other amino acids, then L-arginine undertakes a different role, becoming capable of crossing the blood-brain barrier and stimulating growth hormone release secreted by the anterior pituitary.
Growth hormone serum levels peak during adolescence and begin to drop after age 23. Aging reduces natural growth hormone production, which results in added body fat, reduced muscle tissue, slowed healing, lack of elasticity in the skin and reduced immune function. Human pituitary growth hormone secretion is evidenced in human males, females and children following intravenous administration of 30 grams of arginine (in 30 minutes) in adults and 0.5 grams/kilogram of bodyweight in children. Female response is somewhat higher than male response. Oral administration of L-arginine also results in the release of Human Growth Hormone.
Tumour suppression is evidenced in the presence of L-arginine. In the Barbul study, tumours recurred in 100% of the control animals. But in the arginine-supplemented group, only about 60% of the tumours recurred and the animals with tumours survived longer. Supplementation of arginine in the diet inhibits development and increase in size of cancerous tumours, both chemically induced and naturally occurring.
Insulin can block growth hormone release, so high serum insulin levels are counterproductive to GH release. Insulin itself is capable of stimulating muscle growth, but it also strongly stimulates fat storage. Muscle growth stimulation from insulin is minuscule compared to muscle growth stimulated by growth hormone.
(13 Nov 1997)
arginine 2-monooxygenase <enzyme> Catalyses oxidative decarboxylation or arginine to form gamma-guanidinobutyramide (4-guanidinobutanamide)
Registry number: EC 1.13.12.1
Synonym: arginine decarboxyoxidase
(26 Jun 1999)
arginine amidase <enzyme> A ureahydrolase that catalyses the hydrolysis of arginine and canavanine to yield l-ornithine and urea.
Chemical name: L-Arginine amidinohydrolase
Registry number: EC 3.5.3.1
(12 Dec 1998)
arginine deiminase <enzyme> Arginine converted to citrulline + nh3; consider also protein-arginine deiminase (EC 3.5.3.15)
Registry number: EC 3.5.3.6
Synonym: arginine dihydrolase, arginine converting enzyme, arginine iminohydrolase
(26 Jun 1999)
arginine dihydrolase <enzyme> Arginine converted to citrulline + nh3; consider also protein-arginine deiminase (EC 3.5.3.15)
Registry number: EC 3.5.3.6
Synonym: arginine dihydrolase, arginine converting enzyme, arginine iminohydrolase
(26 Jun 1999)
arginine endopeptidase <enzyme> Cleaves arginine at the carboxyl side in a peptide chain
Registry number: EC 3.4.21.-
Synonym: arginyl endopeptidase
(26 Jun 1999)
arginine esterase <enzyme> Probably refers to an aspect of a proteinase; also index to specific proteinase class
Registry number: EC 3.1.-
Synonym: me-1,arginine ester hydrolase, me-2, me 1,me 2, arginine esterase a, esterase e-ii, esterase a
(26 Jun 1999)
arginine glutamate A compound composed of arginine and glutamic acid, given intravenously to detoxify ammonia; used in the treatment of ammoniaemia resulting from liver dysfunction.
(05 Mar 2000)
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 1 ÆäÀÌÁö: 1
  • Arginine Vasopressin - »õâ The predominant form of mammalian antidiuretic hormone. It is a nonapeptide containing an ARGININE at residue 8 and two disulfide-linked CYSTEINES at residues of 1 and 6. Arg-vasopressin is used to treat DIABETES INSIPIDUS or to improve vasomotor tone and BLOOD PRESSURE.
    Synonyms : Arg-Vasopressin, Argipressin Tannate, Arg Vasopressin
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 1 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 1 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • arginine
    ¾Æ¸£±â´Ñ(¾Æ¹Ì³ë»êÀÇ ÀÏÁ¾)
  • vasopressin
    ¹Ù¼ÒÇÁ·¹½Å(½Å°æ¼º ³úÇϼöüȣ¸£¸óÀÇ ÀÏÁ¾,Ç÷¾Ð »ó½Â,Ç×ÀÌ´¢Á¦)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á